These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 25978381)
41. Prognostic Value of Tumor Associated Macrophage Markers CD163 and CD68 Immunohistochemistry in Classical Hodgkin Lymphoma. Rashed RA; Zaki MAM; Mohamed NAW; Mansou OM; Refaey FAHE Clin Lab; 2021 May; 67(5):. PubMed ID: 33978358 [TBL] [Abstract][Full Text] [Related]
42. CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma. Yoon DH; Koh YW; Kang HJ; Kim S; Park CS; Lee SW; Suh C; Huh J Eur J Haematol; 2012 Apr; 88(4):292-305. PubMed ID: 22044760 [TBL] [Abstract][Full Text] [Related]
43. CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma. Koh YW; Park CS; Yoon DH; Suh C; Huh J PLoS One; 2014; 9(1):e87066. PubMed ID: 24489836 [TBL] [Abstract][Full Text] [Related]
44. Identification of a novel monocytic phenotype in Classic Hodgkin Lymphoma tumor microenvironment. Post GR; Yuan Y; Holthoff ER; Quick CM; Post SR PLoS One; 2019; 14(11):e0224621. PubMed ID: 31714922 [TBL] [Abstract][Full Text] [Related]
45. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. Medrek C; Pontén F; Jirström K; Leandersson K BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040 [TBL] [Abstract][Full Text] [Related]
46. Macrophages and prognosis of oral squamous cell carcinoma: A systematic review. Alves AM; Diel LF; Lamers ML J Oral Pathol Med; 2018 May; 47(5):460-467. PubMed ID: 28940738 [TBL] [Abstract][Full Text] [Related]
47. In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy. Marcelis L; Antoranz A; Delsupehe AM; Biesemans P; Ferreiro JF; Debackere K; Vandenberghe P; Verhoef G; Gheysens O; Cattoretti G; Bosisio FM; Sagaert X; Dierickx D; Tousseyn T Cancer Immunol Immunother; 2020 Sep; 69(9):1751-1766. PubMed ID: 32335702 [TBL] [Abstract][Full Text] [Related]
48. Prognostic significance of CD68 Troiano G; Caponio VCA; Adipietro I; Tepedino M; Santoro R; Laino L; Lo Russo L; Cirillo N; Lo Muzio L Oral Oncol; 2019 Jun; 93():66-75. PubMed ID: 31109698 [TBL] [Abstract][Full Text] [Related]
49. Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma. Dumars C; Ngyuen JM; Gaultier A; Lanel R; Corradini N; Gouin F; Heymann D; Heymann MF Oncotarget; 2016 Nov; 7(48):78343-78354. PubMed ID: 27823976 [TBL] [Abstract][Full Text] [Related]
50. High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination. Arlt A; von Bonin F; Rehberg T; Perez-Rubio P; Engelmann JC; Limm K; Reinke S; Dullin C; Sun X; Specht R; Maulhardt M; Linke F; Bunt G; Klapper W; Vockerodt M; Wilting J; Pukrop T; Dettmer K; Gronwald W; Oefner PJ; Spang R; Kube D Mol Oncol; 2020 Mar; 14(3):571-589. PubMed ID: 31825135 [TBL] [Abstract][Full Text] [Related]
51. High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages. Panico L; Tenneriello V; Ronconi F; Lepore M; Cantore N; Dell'Angelo AC; Ferbo L; Ferrara F Leuk Lymphoma; 2015 Jun; 56(6):1636-42. PubMed ID: 25098425 [TBL] [Abstract][Full Text] [Related]
52. The clinicopathological impact of tumor-associated macrophages in patients with cutaneous malignant melanoma. Asai Y; Yanagawa N; Osakabe M; Yamada N; Sugimoto R; Sato A; Ito K; Koike Y; Tanji T; Sakuraba M; Sato T; Sugai T J Surg Oncol; 2024 Feb; 129(2):381-391. PubMed ID: 37916518 [TBL] [Abstract][Full Text] [Related]
53. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells. Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417 [TBL] [Abstract][Full Text] [Related]
54. Type 2 Endometrial Cancer is Associated With a High Density of Tumor-Associated Macrophages in the Stromal Compartment. Kelly MG; Francisco AM; Cimic A; Wofford A; Fitzgerald NC; Yu J; Taylor RN Reprod Sci; 2015 Aug; 22(8):948-53. PubMed ID: 25701837 [TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical characterization and morphometric analysis of macrophages in rat mammary tumors. Ong CB; Brandenberger C; Kiupel M; Kariagina A; Langohr IM Vet Pathol; 2015 Mar; 52(2):414-8. PubMed ID: 24842486 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas. Menter T; Bodmer-Haecki A; Dirnhofer S; Tzankov A Hum Pathol; 2016 Aug; 54():17-24. PubMed ID: 27045512 [TBL] [Abstract][Full Text] [Related]
57. Prediction of steroid demand in the treatment of patients with ulcerative colitis by immunohistochemical analysis of the mucosal microenvironment and immune checkpoint: role of macrophages and regulatory markers in disease severity. Tsuda S; Carreras J; Kikuti YY; Nakae H; Dekiden-Monma M; Imai J; Tsuruya K; Nakamura J; Tsukune Y; Uchida T; Matsushima M; Roncador G; Suzuki T; Nakamura N; Mine T Pathol Int; 2019 May; 69(5):260-271. PubMed ID: 30990953 [TBL] [Abstract][Full Text] [Related]
58. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma. Kim KJ; Wen XY; Yang HK; Kim WH; Kang GH PLoS One; 2015; 10(12):e0144192. PubMed ID: 26714314 [TBL] [Abstract][Full Text] [Related]
59. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Zaki MA; Wada N; Ikeda J; Shibayama H; Hashimoto K; Yamagami T; Tatsumi Y; Tsukaguchi M; Take H; Tsudo M; Morii E; Aozasa K Virchows Arch; 2011 Oct; 459(4):361-6. PubMed ID: 21874508 [TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of macrophage polarization in early stage oral squamous cell carcinomas. Weber M; Iliopoulos C; Moebius P; Büttner-Herold M; Amann K; Ries J; Preidl R; Neukam FW; Wehrhan F Oral Oncol; 2016 Jan; 52():75-84. PubMed ID: 26728105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]